【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 8
List of Figures 9
Introduction 10
Global Markets Direct Report Coverage 10
Peripheral Artery Occlusive Disease (PAOD) Overview 11
Therapeutics Development 12
Pipeline Products for Peripheral Artery Occlusive Disease (PAOD) – Overview 12
Pipeline Products for Peripheral Artery Occlusive Disease (PAOD) – Comparative Analysis 13
Peripheral Artery Occlusive Disease (PAOD) – Therapeutics under Development by Companies 14
Peripheral Artery Occlusive Disease (PAOD) – Pipeline Products Glance 18
Late Stage Products 18
Clinical Stage Products 19
Early Stage Products 20
Unknown Stage Products 21
Peripheral Artery Occlusive Disease (PAOD) – Products under Development by Companies 22
Peripheral Artery Occlusive Disease (PAOD) – Companies Involved in Therapeutics Development 26
Annexin Pharmaceuticals AB 26
Apceth GmbH & Co. KG 27
AstraZeneca PLC 28
Athersys, Inc. 29
Bayer AG 30
Betagenon AB 31
Cardiolynx AG 32
CardioVascular BioTherapeutics, Inc. 33
Celgene Corporation 34
Cytokinetics, Inc. 35
Diffusion Pharmaceuticals LLC 36
DNAVEC Corporation 37
Genovate Biotechnology Co., LTD. 38
Grifols, S.A. 39
Human Stem Cells Institute 40
Kowa Company, Ltd. 41
Lacer, S.A. 42
Ligand Pharmaceuticals, Inc. 43
LTT Bio-Pharma Co., Ltd. 44
miRagen Therapeutics, Inc. 45
Multi Gene Vascular Systems Ltd 46
Nuo Therapeutics, Inc. 47
Pluristem Therapeutics Inc. 48
Proteon Therapeutics, Inc. 49
Recardio GmbH 50
RegenoCELL Therapeutics, Inc. 51
Rigel Pharmaceuticals, Inc. 52
Sagene Pharmaceuticals, Inc. 53
Stemedica Cell Technologies, Inc. 54
Taisho Toyama Pharmaceutical Co., Ltd. 55
Theravasc, Inc. 56
vasopharm GmbH 57
ViroMed Co., Ltd. 58
Peripheral Artery Occlusive Disease (PAOD) – Therapeutics Assessment 59
Assessment by Monotherapy Products 59
Assessment by Combination Products 60
Assessment by Target 61
Assessment by Mechanism of Action 63
Assessment by Route of Administration 65
Assessment by Molecule Type 67
Drug Profiles 69
(cilostazol + organic nitrate) ER – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
AEM-28 – Drug Profile 70
Product Description 70
Mechanism of Action 70
R&D Progress 70
ALD-301 – Drug Profile 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
Alecmestencel-T – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
alprostadil – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
Annexin A-5 – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
AP-01 – Drug Profile 77
Product Description 77
Mechanism of Action 77
R&D Progress 77
cilostazol CR – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
clopidogrel bisulfate – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
CVBT-141C – Drug Profile 80
Product Description 80
Mechanism of Action 80
R&D Progress 80
DVC1-0101 – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
ELS-140 – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
Gene Therapy for Critical Limb Ischemia and Peripheral Arterial Disease – Drug Profile 83
Product Description 83
Mechanism of Action 83
R&D Progress 83
Gene Therapy to Activate Vascular Endothelial Growth Factor for Cardiovascular Disease and Central Nervous System Disorders – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
Human Plasmin – Drug Profile 85
Product Description 85
Mechanism of Action 85
R&D Progress 85
K-134 – Drug Profile 87
Product Description 87
Mechanism of Action 87
R&D Progress 87
LA-419 – Drug Profile 88
Product Description 88
Mechanism of Action 88
R&D Progress 88
LT-0101 – Drug Profile 89
Product Description 89
Mechanism of Action 89
R&D Progress 89
Mesenchymal Stem Cells – Drug Profile 90
Product Description 90
Mechanism of Action 90
R&D Progress 90
MGN-6114 – Drug Profile 92
Product Description 92
Mechanism of Action 92
R&D Progress 92
MultiGeneAngio – Drug Profile 93
Product Description 93
Mechanism of Action 93
R&D Progress 93
MultiGeneGraft – Drug Profile 94
Product Description 94
Mechanism of Action 94
R&D Progress 94
MultiStem – Drug Profile 95
Product Description 95
Mechanism of Action 95
R&D Progress 95
O-304 – Drug Profile 98
Product Description 98
Mechanism of Action 98
R&D Progress 98
PDA-002 – Drug Profile 99
Product Description 99
Mechanism of Action 99
R&D Progress 99
R-118 – Drug Profile 100
Product Description 100
Mechanism of Action 100
R&D Progress 100
REC-03 – Drug Profile 101
Product Description 101
Mechanism of Action 101
R&D Progress 101
rivaroxaban – Drug Profile 102
Product Description 102
Mechanism of Action 102
R&D Progress 102
selegiline + Antiplatelet Drugs – Drug Profile 107
Product Description 107
Mechanism of Action 107
R&D Progress 107
sodium nitrite – Drug Profile 108
Product Description 108
Mechanism of Action 108
R&D Progress 108
Stem Cell Therapy for Cardiovascular Diseases – Drug Profile 110
Product Description 110
Mechanism of Action 110
R&D Progress 110
Stem Cell Therapy for Cardiovascular Diseases – Drug Profile 112
Product Description 112
Mechanism of Action 112
R&D Progress 112
SYN-20112312RU – Drug Profile 113
Product Description 113
Mechanism of Action 113
R&D Progress 113
ticagrelor – Drug Profile 114
Product Description 114
Mechanism of Action 114
R&D Progress 114
tirasemtiv – Drug Profile 117
Product Description 117
Mechanism of Action 117
R&D Progress 117
transcrocetinate sodium – Drug Profile 123
Product Description 123
Mechanism of Action 123
R&D Progress 123
TXA-127 – Drug Profile 124
Product Description 124
Mechanism of Action 124
R&D Progress 124
VAS-2870 – Drug Profile 126
Product Description 126
Mechanism of Action 126
R&D Progress 126
VM-202 – Drug Profile 127
Product Description 127
Mechanism of Action 127
R&D Progress 127
vonapanitase – Drug Profile 129
Product Description 129
Mechanism of Action 129
R&D Progress 129
Peripheral Artery Occlusive Disease (PAOD) – Recent Pipeline Updates 130
Peripheral Artery Occlusive Disease (PAOD) – Dormant Projects 166
Peripheral Artery Occlusive Disease (PAOD) – Discontinued Products 171
Peripheral Artery Occlusive Disease (PAOD) – Product Development Milestones 173
Featured News & Press Releases 173
Feb 02, 2015: The Small molecule AMPK activator O304 acts as an oral PCSK9 inhibitor 173
Jan 08, 2015: Journal of Cardiovascular Pharmacology Publishes Positive Nonclinical Results of Proteon Therapeutics’ PRT-201 in Peripheral Artery Disease 173
Sep 29, 2014: Annexin Pharmaceuticals Announces Patent 174
Sep 02, 2014: Capstone Therapeutics Announces Phase 1a Results for AEM-28 Showing Safety and Biomarker Efficacy Signals 174
Jul 09, 2014: Development Of Russian Innovative Drug For Peripheral Arterial Disease Is Supported By The Council Of Maryland Biotech Companies (USA) 175
Mar 17, 2014: AstraZeneca Announces Progress on Global PARTHENON Clinical Trial Program with BRILINTA in High-Risk Cardiovascular Disease Patient Populations in Advance of American College of Cardiology Scientific Session 176
Mar 06, 2014: Rigel Announces Publication of R118 AMPK Activator Research 178
Nov 13, 2013: Pluristem Receives Regulatory Approval to Extend Its Phase II Study of PLX-PAD Cells in the Treatment of Intermittent Claudication to South Korea 179
Oct 02, 2013: Pluristem Receives Israeli Ministry of Health Approval to Expand Its Phase II Clinical Trial in Intermittent Claudication to Israel 180
Sep 16, 2013: FDA Lifts Clinical Hold of Pluristem’s Phase II Intermittent Claudication Study 180
Appendix 181
Methodology 181
Coverage 181
Secondary Research 181
Primary Research 181
Expert Panel Validation 181
Contact Us 181
Disclaimer 182
【レポート販売概要】
■ タイトル：末梢動脈閉塞性疾患(Peripheral Artery Occlusive Disease (PAOD))：治療薬開発パイプライン動向（2015年上半期版）■ 英文：Peripheral Artery Occlusive Disease (PAOD) - Pipeline Review, H1 2015
■ 発行日：2015年3月11日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6257IDB
■ 調査対象地域：グローバル
- 抗体薬物複合体（ADC）の世界市場：シアトルジェネティクス技術、ImmunoGen技術、Immunomedics技術About Antibody Drug Conjugates ADCs, empowered monoclonal antibodies (mAbs), use chemical linkers with labile bonds to attach biologically active substances. ADCs target mAbs with the cancer killing ability of cytotoxic drugs, allowing sensitive discernment between healthy and diseased tissue. Antibodies are the proteins produced by B-cells (from bone marrow) in the immune system. These proteins a …
- バイオディーゼルの世界市場：菜種油、大豆油、パーム油About biodiesel There has been an unprecedented interest in biofuels over the past decade, primarily due to increase in crude oil prices, as this is affecting the economy of many countries that do not have significant oil and gas reserves. High dependence on non-renewable fuels has resulted in economic as well as environmental concerns, such as rising GHG emission levels. Several developing and de …
- 2014年戦略提言：世界の内分泌機能検査市場Complete report $8,500. DataPack (test volumes, sales forecasts, supplier shares) $5,500.This new 327-page report from Venture Planning Group contains 75 tables and provides analysis of the global endocrine function diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, market shares and strategic profiles of leading suppliers. The repo …
- 世界の企業用モバイルセキュリティソフトウェア市場About Mobile Enterprise Security Software Mobile enterprise security software secures the mobile workforce. It delivers a simplified, streamlined way to enable productivity with confidence in a world where users, and their devices, go everywhere and anywhere. Mobile productivity presents risks to mobile devices and data, including malware, loss, theft, and unauthorized access. Businesses work hard …
- 世界のフレキシブルウェアラブルパソコンに関する特許出願動向This research report presents the recent quarter review of the patent applications in the flexible wearable computer industry. The report, which is based on the survey of USPTO database, includes patent application volume—both overall and by assignee country, assignee rankings, IPC rankings, and USPC rankings. The report finds that the industry's patent applications arrived at 429 in the sec …
- メキシコの末梢血管処置用機器市場見通し（～2021）Mexico Peripheral Vascular Procedures Outlook to 2021 Summary GlobalData’s new report, "Mexico Peripheral Vascular Procedures Outlook to 2021", provides key procedures data on the Mexico Peripheral Vascular Procedures. The report provides procedure volumes within market segments - Aortic Open Repair Procedures, Aortic Stent Graft Procedures, Carotid Artery Embolic Protection Procedures, Deep Seate …
- Ambu A/S：市場シェア分析Ambu A/S Market Share Analysis Summary GlobalData’s new report, “Ambu A/S Market Share Analysis” provides in-depth information on Ambu A/S’s market position in the different medical equipment markets it operates in. The report provides Ambu A/S market share information in four key market categories – Patient Monitoring Accessories, Airway and Anesthesia Devices, Respiratory Devices and Respiratory …
- ベクトル信号発生器の世界市場2018-2022About vector signal generator Vector signal generator is a test and measurement equipment used for testing complex waveforms. This equipment was developed considering the emergence of new communication technologies and consists of a high-end radio-frequency (RF) signal generator with an IQ modulator. Technavio’s analysts forecast the Global vector signal generator market to grow at a CAGR of 2.67% …
- 世界の家電市場予測2018The global consumer electronics industry has been growing significantly for the past few years due to the innovative technical developments in the sector across the globe. The industry is entering into the age of convergence wherein entirely different streams of digital-based audio, video and information technology unite and merge, removing entry hurdles across various markets and the whole indust …
- 膝関節置換術：グローバル市場分析と予測MediPoint: Knee Replacement - Global Analysis and Market Forecasts Summary The current knee replacement market is a crowded space, with an increasing number of companies offering a myriad of partial, primary/total, and revision prostheses to meet orthopedic surgeons’ demands in the management of knee diseases, primarily osteoarthritis. Worldwide, the primary/total knee segment represents about 80– …
- 世界の繊維化学薬品市場（2014-2018）TechNavio's analysts forecast the Global Textile Chemicals market to grow at a CAGR of 3.60 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased demand for finishing chemicals. The Global Textile Chemicals market has also been witnessing the development of eco-friendly products and bio-auxiliaries. However, the rising environmental concerns …
- 液体用カートン（紙容器）の世界市場2015-2019About Liquid Packaging Carton Liquid packaging cartons provide liquid food and drinks with support, protection from the external environment, and resistance from tampering. They also aid in the reliable distribution of liquid products among the value chain and reduce post-production damage. Vendors in the Global Liquid Packaging Carton market take customers' needs into consideration and manufactur …
- Hess Corporation：石油・ガスの開発・生産動向及びコスト分析- Q2, 2013Hess Corporation Oil & Gas Exploration and Production Operations and Cost Analysis - Q2, 2013 Summary Hess Corporation Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for key o …
- 世界のビジョンケア機器開発動向：医療機器パイプライン分析2015Vision Care - Medical Devices Pipeline Assessment, 2015 Summary GlobalData's Medical Devices sector report, “Vision Care - Medical Devices Pipeline Assessment, 2015" provides an overview of Vision Care currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews maj …
- 世界の液体クロマトグラフィーシステム市場動向（2014-2018）About Liquid Chromatography Systems Liquid chromatography systems are used for the purification of biochemical, environmental, and other chemical entities using the principle of separation chemistry. The major compounds that are separated using liquid chromatography are metabolites, proteins, carbohydrates, and salts. Liquid chromatography systems are routinely used in pharmaceutical companies and …
